Hoxton Planning & Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Sell |
3,404
-409
| -11% | -$45.3K | 0.13% | 133 |
|
|
2025
Q1 | $427K | Sell |
3,813
-70
| -2% | -$7.84K | 0.16% | 121 |
|
|
2024
Q4 | $359K | Buy |
3,883
+3
| +0.1% | +$277 | 0.14% | 132 |
|
|
2024
Q3 | $325K | Buy |
3,880
+480
| +14% | +$40.2K | 0.13% | 144 |
|
|
2024
Q2 | $233K | Buy |
3,400
+548
| +19% | +$37.6K | 0.11% | 141 |
|
|
2024
Q1 | $209K | Buy |
2,852
+9
| +0.3% | +$659 | 0.1% | 156 |
|
|
2023
Q4 | $230K | Sell |
2,843
-62
| -2% | -$5.02K | 0.12% | 130 |
|
|
2023
Q3 | $218K | Sell |
2,905
-84
| -3% | -$6.3K | 0.14% | 126 |
|
|
2023
Q2 | $230K | Sell |
2,989
-485
| -14% | -$37.4K | 0.14% | 125 |
|
|
2023
Q1 | $288K | Sell |
3,474
-103
| -3% | -$8.55K | 0.16% | 118 |
|
|
2022
Q4 | $307K | Buy |
+3,577
| New | +$307K | 0.16% | 118 |
|